Skip to search formSkip to main contentSkip to account menu

HLA-DR5 Antigen

Known as: human histocompatibility complex derived antigens-DR5, HLA-DR5 Antigen [Chemical/Ingredient], HLA-DR5 
A broad-specificity HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*11 and DRB1*12 alleles.
National Institutes of Health

Related topics

Related topics

3 relations
In Bloodaspects of radiation effectsphysiological aspects

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
A Comparison between RAVE DR5 and Gaia DR2 Radial Velocities
This research note presents a comparison of radial velocities between the RAVE DR5 data release with Gaia DR2. RAVE DR5 and Gaia… 
Review
2018
Review
2018
The role of MHC class II genes and post-translational modifications in celiac disease
Our increasing understanding of the etiology of celiac disease, previously considered a simple food hypersensitivity disorder… 
2016
2016
Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain–FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study
Death receptor 5 (DR5)-induced apoptosis that prioritizes the death of tumor cells has been proposed as one of the promising… 
Review
2012
Review
2012
New ultracool subdwarfs identified in large-scale surveys using Virtual Observatory tools (Corrigendum) - I. UKIDSS LAS DR5 vs. SDSS DR7
Aims. The aim of the project is to improve our knowledge of the low-mass and low-metallicity population to investigate the… 
2012
2012
Abstract 3853: TAS266, a novel tetrameric nanobody agonist targeting death receptor 5 (DR5), elicits superior antitumor efficacy than conventional DR5-targeted approaches
Preferential induction of apoptosis in cancer cells has been the objective of therapeutic strategies targeting apoptotic pathways… 
2011
2011
신규 항 dr5 항체
본 발명은 암, 자기 면역 질환 또는 염증성 질환에 대하여 치료 효과를 갖는 항체에 관한 것이다. 즉, 본 발명은 데스 도메인 함유 수용체 발현 세포에 대하여 아포토시스를 통한 세포 상해 활성을 나타내는 항체에 관한 것이다. 본 발명의 과제는 암에 대하여 치료 효과를 갖는 의약품을 제공하는 것이다. 세포에 아포토시스를 유도할 수 있는 신규 항 DR5 항체가 기존의 항 DR5 항체에 비해, 현저한 세포 상해 활성을 갖는 것을 나타낸다. 
2008
2008
Charakterisierung des Auxin-bindenden Proteins 1
Neben den bekannten Auxinrezeptoren TIR1, AFB1, AFB2 und AFB3 wird auch das Auxin-bindende Protein 1 (ABP1) als Rezeptorkandidat… 
2007
2007
Effects of anti-human DR5 monoclonalantibody(mDRA-6) on Jurkat cell
Objective:To observe apoptotic effect of anti-human DR5(death receptor 5 of TRAIL) monoclonal antibody(mDRA-6) on Jurkat cell… 
1993
1993
[Effect of HLA- genotype on bacterial colonization and antigenemia in patients with infiltrative pulmonary tuberculosis].
150 patients with infiltrative tuberculosis (IT) and 135 healthy subjects were subjected to HLA-typing. Clinico-immunogenetic… 
1983
1983
HLA-DR antigens in progressive systemic sclerosis (scleroderma).
Typing at the HLA-DR locus was performed in 125 North American white patients with progressive systemic sclerosis (PSS). We could… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)